Beta Bionics Mint Patch Pump: FDA Clearance, Launch, CGMs (2026)

Beta Bionics has FDA clearance for Mint, a two piece insulin patch pump designed to be smaller than Omnipod 5 that never needs recharging, with a US launch through pharmacies planned for early 2027.

Presented By Our Partners

Quick answer, verified October 20, 2026

The FDA has cleared Mint, Beta Bionics’ insulin patch pump. Beta Bionics plans a full US launch in the first quarter of 2027, sold only through the pharmacy channel. Mint is controlled from a smartphone app and works with Dexcom G7, Dexcom G7 15 Day and FreeStyle Libre 3 Plus sensors.

Wear time: each disposable patch lasts 3 days, plus a 12 hour grace period.
Reservoir: 200 units of insulin.
Power: never needs recharging.
Waterproofing: IPX8, down to 5 feet for 60 minutes.
Price: not announced; Beta Bionics says pharmacy distribution is part of its focus on affordability.

The short verdict

Mint is Beta Bionics’ answer to Omnipod 5, the patch pump that leads the tubeless market. Beta Bionics built its reputation on the iLet Bionic Pancreas, a tubed pump whose fully adaptive algorithm starts from body weight alone and replaces carb counting with simple meal announcements. Mint is designed to bring that experience to a patch for people who do not want tubing. The launch is still months away, and pricing has not been published.

Mint at a glance

Type: two piece insulin patch pump, reusable part plus disposable patch
Wear: 3 days per patch plus 12 hour grace period
Reservoir: 200 units
Charging: none needed
Waterproof: IPX8, 5 feet for 60 minutes
Control: smartphone app for iOS and Android, with over the air firmware updates
CGMs: Dexcom G7, Dexcom G7 15 Day, FreeStyle Libre 3 Plus
Launch: full US commercial launch planned for Q1 2027, pharmacy channel only

How Mint relates to the iLet Bionic Pancreas

The FDA first cleared the iLet ACE Pump and iLet Dosing Decision Software in May 2023 for people with type 1 diabetes aged 6 and older. The iLet algorithm is initialized with only the user’s body weight, adjusts basal and correction insulin on its own, and asks users to announce meals as small, medium or large instead of counting carbs. Beta Bionics says the iLet algorithm has been used by more than 40,000 people with diabetes, and that Mint is designed to extend that experience to a patch form factor.

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

What comes next: 3D Intelligence

Alongside the Mint clearance, Beta Bionics announced 3D Intelligence, a next generation dosing algorithm submitted to the FDA through a 510(k). It offers three selectable dosing experiences and is intended to power future Mint 3D and iLet 3D systems, pending FDA clearance.

How Mint compares

Omnipod 5: the current patch pump leader. Mint is designed to be smaller and never needs recharging.
Tubed pumps: iLet, Tandem and Medtronic MiniMed pumps remain options for people who prefer them; Tandem and MiniMed are also pursuing tubeless designs.
Sensors: Mint works with Dexcom G7 and FreeStyle Libre 3 Plus. Abbott also expects its glucose and ketone sensor, Libre Duo, to work with Beta Bionics’ iLet by the end of 2026.

Who should watch for Mint

People with diabetes who use insulin, want a tubeless pump and already use a Dexcom G7 or FreeStyle Libre 3 Plus sensor. Because Mint will be sold through pharmacies, coverage may follow pharmacy benefits rather than the durable medical equipment route many pumps use; check with your insurer once pricing is announced, and confirm the labeled indication with your care team.

Frequently asked questions

When will Beta Bionics Mint be available?

Beta Bionics plans a full US commercial launch in the first quarter of 2027, sold exclusively through the pharmacy channel.

Which CGMs work with Mint?

Dexcom G7, Dexcom G7 15 Day and Abbott FreeStyle Libre 3 Plus.

How long does a Mint patch last?

Each disposable patch is designed for 3 days of wear, with an additional 12 hour grace period, and holds 200 units of insulin.

Does Mint need charging?

No. Beta Bionics says Mint never requires recharging.

Sources

This article is for general information and is not medical advice. Talk with your diabetes care team before changing insulin delivery.

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

No spam. Unsubscribe anytime. We respect your inbox.

Beta Bionics Mint: FDA Cleared Patch Pump, Launch Date and CGMs